# Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

> **NCT00363948** · PHASE3 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 188 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Placebo
- **DRUG:** Sitagliptin phosphate

## Key facts

- **NCT ID:** NCT00363948
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-02
- **Final completion:** —
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00363948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00363948, "Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00363948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*